Literature DB >> 19252955

Visual hallucinations in a patient with adult onset acid maltase deficiency disorder.

Ritesh Patil1, Jack L Depriest.   

Abstract

A 66-year-old male presented with visual hallucinations. He had chronically elevated serum creatine kinase (CK) levels without muscle weakness. His hospital course was complicated by hypercapnic respiratory failure requiring mechanical ventilation. His hallucinations completely subsided on mechanical ventilation. Elevated CK levels prompted a muscle biopsy, which showed myopathy consistent with acid maltase deficiency disorder (AMDD). This is the first reported case of adult onset AMDD presenting with psychiatric symptoms. Our objective in reporting this case is to encourage early recognition of neuromuscular respiratory failure in AMDD and to reinforce that respiratory failure may develop without associated extremity muscle weakness.

Entities:  

Mesh:

Year:  2009        PMID: 19252955      PMCID: PMC2669858          DOI: 10.1007/s11606-009-0923-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  11 in total

1.  Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy.

Authors:  Alfred E Slonim; Linda Bulone; Teresia Goldberg; Jennifer Minikes; Efrat Slonim; Joseph Galanko; Frank Martiniuk
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

2.  A retrospective study on improvements in nightmares and post-traumatic stress disorder following treatment for co-morbid sleep-disordered breathing.

Authors:  B Krakow; C Lowry; A Germain; L Gaddy; M Hollifield; M Koss; D Tandberg; L Johnston; D Melendrez
Journal:  J Psychosom Res       Date:  2000-11       Impact factor: 3.006

3.  Respiratory failure and sleep in neuromuscular disease.

Authors:  P T Bye; E R Ellis; F G Issa; P M Donnelly; C E Sullivan
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

4.  Sleep-disordered breathing and respiratory failure in acid maltase deficiency.

Authors:  U Mellies; R Ragette; C Schwake; M Baethmann; T Voit; H Teschler
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

5.  Respiratory failure in Pompe disease: treatment with noninvasive ventilation.

Authors:  U Mellies; F Stehling; C Dohna-Schwake; R Ragette; H Teschler; T Voit
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

Review 6.  Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).

Authors:  Nina Raben; Paul Plotz; Barry J Byrne
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

7.  Disease severity in children and adults with Pompe disease related to age and disease duration.

Authors:  M L C Hagemans; L P F Winkel; W C J Hop; A J J Reuser; P A Van Doorn; A T Van der Ploeg
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

8.  Treatment refractory psychosis remitted upon treatment with continuous positive airway pressure: a case report.

Authors:  Alina Karanti; Mikael Landén
Journal:  Psychopharmacol Bull       Date:  2007

9.  Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases.

Authors:  M Klink; S F Quan
Journal:  Chest       Date:  1987-04       Impact factor: 9.410

Review 10.  Physical therapy management of Pompe disease.

Authors:  Laura Elizabeth Case; Priya Sunil Kishnani
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

View more
  1 in total

1.  Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism.

Authors:  George Chinedu Ezeji; Taiga Inoue; Gul Bahtiyar; Alan Sacerdote
Journal:  BMJ Case Rep       Date:  2015-02-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.